Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases.
Total raised: $75M
Investors 2
| Date | Name | Website |
| - | Catalio Ca... | cataliocap... |
| 09.02.2024 | Hawktail M... | hawktail.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.08.2023 | Series A | $75M | BioVenture... |
Mentions in press and media 5
| Date | Title | Description |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |
| 18.08.2023 | Georgiamune: Clinical-Stage Biotechnology Company Closes $75 Million In Funding | Georgiamune – a privately held clinical-stage biotechnology company – recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for GIM-122, a dual-functioning monoclon... |
| 16.08.2023 | DC Money Moves: ASRC Federal subsidiary secures an $8B contract from NOAA | Money Moves is a column where we chart the funding raises of tech companies across the region. Have a tip? Email us at dc@technical.ly. Reston-based ASRC Federal subsidiary Data Networks, secured a spot on a National Oceanic and Atmospheric... |
| 09.08.2023 | Georgiamune Closes $75M Series A Financing | Georgiamune Inc., a Gaithersburg, Md.-based clinical stage biotechnology company working in the fields of oncology and autoimmune diseases, completed a $75M Series A financing. General Catalyst and Parker Institute for Cancer Immunotherapy ... |
| - | Georgiamune | “Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases.” |